Cargando…

HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications

Chronic hepatitis B virus (HBV) infection represents a worldwide public health concern with approximately 250 million people chronically infected and at risk of developing liver cirrhosis and hepatocellular carcinoma. Nucleos(t)ide analogues (NUC) are the most widely used therapies for HBV infection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boni, Carolina, Barili, Valeria, Acerbi, Greta, Rossi, Marzia, Vecchi, Andrea, Laccabue, Diletta, Penna, Amalia, Missale, Gabriele, Ferrari, Carlo, Fisicaro, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600394/ https://www.ncbi.nlm.nih.gov/pubmed/31195619 http://dx.doi.org/10.3390/ijms20112754

Ejemplares similares

Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches
por: Fisicaro, Paola, et al.
Publicado: (2020)

The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy
por: Fisicaro, Paola, et al.
Publicado: (2019)

Unraveling the Multifaceted Nature of CD8 T Cell Exhaustion Provides the Molecular Basis for Therapeutic T Cell Reconstitution in Chronic Hepatitis B and C
por: Barili, Valeria, et al.
Publicado: (2021)

Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection
por: Montali, Ilaria, et al.
Publicado: (2022)

Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro
por: Rossi, Marzia, et al.
Publicado: (2023)

Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers
por: Barili, Valeria, et al.
Publicado: (2023)

Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection
por: Barili, Valeria, et al.
Publicado: (2020)

FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses
por: Tiezzi, Camilla, et al.
Publicado: (2023)

Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm
por: Boni, Carolina, et al.
Publicado: (2021)

Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
por: Zecca, Alessandra, et al.
Publicado: (2021)

Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer
por: Zecca, Alessandra, et al.
Publicado: (2022)

Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations
por: Tiezzi, Camilla, et al.
Publicado: (2023)

Heterologous T cell immunity in severe hepatitis C virus infection
por: Urbani, Simona, et al.
Publicado: (2005)

Contribution of Herpesvirus Specific CD8 T Cells to Anti-Viral T Cell Response in Humans
por: Sandalova, Elena, et al.
Publicado: (2010)

T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma
por: Fisicaro, Paola, et al.
Publicado: (2022)

HBV-Specific Adaptive Immunity
por: Bertoletti, Antonio, et al.
Publicado: (2009)

Effector CD8(+) T cell-derived interleukin-10 enhances acute liver immunopathology
por: Fioravanti, Jessica, et al.
Publicado: (2017)

An HBV-encoded miRNA activates innate immunity to restrict HBV replication
por: Zhao, Xiaoqing, et al.
Publicado: (2019)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)

Immunological and Molecular Correlates of Disease Recurrence after Liver Resection for Hepatocellular Carcinoma
por: Cariani, Elisabetta, et al.
Publicado: (2012)

The Role of Immune Cells in Chronic HBV Infection
por: Li, Hai-Jun, et al.
Publicado: (2015)

HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)

HBV Infection in HIV-Driven Immune Suppression
por: Sarmati, Loredana, et al.
Publicado: (2019)

The Interactions Between HBV and the Innate Immunity of Hepatocytes
por: Megahed, Fayed Attia Koutb, et al.
Publicado: (2020)

Innate Immunity, Inflammation, and Intervention in HBV Infection
por: Yang, Ge, et al.
Publicado: (2022)

Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals
por: Di Stefano, Mariantonietta, et al.
Publicado: (2023)

HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles
por: Shata, Mohamed Tarek M., et al.
Publicado: (2019)

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
por: Colagrossi, Luna, et al.
Publicado: (2018)

Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B
por: Svicher, Valentina, et al.
Publicado: (2021)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo
por: Zhu, Wenbo, et al.
Publicado: (2012)

Antibiotic-induced gut bacteria depletion has no effect on HBV replication in HBV immune tolerance mouse model
por: Bu, Yanan, et al.
Publicado: (2023)

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals
por: Lee, Z., et al.
Publicado: (2015)

Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
por: Sablon, Erwin, et al.
Publicado: (2005)

The Molecular Pathology and Clinical Impact of HBV Genetic Variability
por: Chemin, Isabelle, et al.
Publicado: (2011)

HBV DNA Integration: Molecular Mechanisms and Clinical Implications
por: Tu, Thomas, et al.
Publicado: (2017)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Trained immunity in newborn infants of HBV-infected mothers
por: Hong, Michelle, et al.
Publicado: (2015)

KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma
por: Cariani, Elisabetta, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_955q6kcleoim6vadc6pi9jppdc